Skip to content
StockMarketAgent
Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

LON/0RNX stock hub

LON/0RNX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0RNXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
957.7M
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0RNX
In the news

Latest news · LON/0RNX

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.5
P25 12.9P50 16.9P75 23.5
Trailing P/E16.9
P25 15.9P50 22.9P75 35.8
ROE14.2
P25 -54.2P50 2.1P75 13.7
ROIC5.9
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0RNX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
222
Groups with data
11
Currency
SEK
Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Sweden
Country code
UK
Employees
41,118
Employees Change
22,063%
Employees Change Percent
138.4
Enterprise value
SEK 2B
Exchange
London Stock Exchange
Financial currency
SEK
First seen
2026-05-10
Industry
Medical Care Facilities
Last refreshed
2026-05-10
Market cap
SEK 957.7M
Price
SEK 148
Price currency
SEK
Rev Per Employee
32,286.72x
Sector
Healthcare
Sic
8050
Symbol
lon/0RNX
Website
https://www.ambea.se

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
5.93%
EV Earnings
35.32x
EV/EBIT
18.34x
EV/EBITDA
8.58x
EV/FCF
12.77x
EV/Sales
1.51x
FCF yield
16.41%
Forward P/E
13.45x
P/B ratio
2.33x
P/E ratio
16.86x
P/S ratio
0.72x
PE Ratio10 Y
18.81x
PE Ratio3 Y
13.12x
PE Ratio5 Y
14.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
8.24%
EBITDA Margin
9.7%
FCF margin
11.84%
Gross margin
27.45%
Gross Profit
SEK 364.5M
Gross Profit Growth
15.42%
Gross Profit Growth Q
23.94%
Gross Profit Growth3 Y
12.09%
Gross Profit Growth5 Y
11.03%
Net Income
SEK 56.8M
Net Income Growth
14.24%
Net Income Growth Q
42.24%
Net Income Growth Quarters
2%
Net Income Growth3 Y
24.5%
Net Income Growth5 Y
15.79%
Pretax Margin
5.53%
Profit Margin
4.28%
Profit Per Employee
SEK 1,382
ROA
4.37
Roa5y
3.5
ROCE
8.33
ROE
14.22
Roe5y
9.67
ROIC
5.9
Roic5y
5.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

23
MetricValue
Cagr1y
37.29%
Cagr3y
56.78%
Cagr5y
19.85%
Div CAGR3
22.06%
Div CAGR5
13.67%
EPS Growth
15.99
EPS Growth Q
45.32
EPS Growth Quarters
2
EPS Growth3 Y
29.14
EPS Growth5 Y
18.68
FCF Growth
8.82%
FCF Growth Q
-27.17%
FCF Growth3 Y
12.34%
FCF Growth5 Y
8.81%
OCF Growth
7.93%
OCF Growth Q
-23.53%
OCF Growth3 Y
12.17%
OCF Growth5 Y
8.43%
Revenue Growth
15.3x
Revenue Growth Q
16.55x
Revenue Growth Quarters
11x
Revenue Growth3 Y
9.26x
Revenue Growth5 Y
8.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
SEK 0.85
Assets
SEK 1.7B
Cash
SEK 13.8M
Current Assets
SEK 159.3M
Current Liabilities
SEK 355.3M
Debt
SEK 1.1B
Debt EBITDA
SEK 4.54
Debt Equity
SEK 2.59
Debt FCF
SEK 6.76
Equity
SEK 411.1M
Interest Coverage
2.7
Liabilities
SEK 1.3B
Long Term Assets
SEK 1.5B
Long Term Liabilities
SEK 902.9M
Net Cash
SEK -1B
Net Cash By Market Cap
SEK -110
Net Debt EBITDA
SEK 8.14
Net Debt Equity
SEK 2.55
Net Debt FCF
SEK 6.67
Tangible Book Value
SEK -303.7M
Tangible Book Value Per Share
SEK -3.73
WACC
5.32

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
0.45
Net Working Capital
SEK -22M
Quick ratio
0.41
Working Capital
SEK -195.9M
Working Capital Turnover
SEK -0.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
1.64%
Dividend Growth
53.71%
Dividend Growth Years
3%
Dividend per share
SEK 0.17
Dividend Years
5
Dividend Yield
0.12%
Ex Div Date
2025-05-15
Last Dividend
SEK 0.17
Payout Frequency
Annual
Payout Ratio
25.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
37.26%
200-day SMA
130.8
3Y total return
285.48%
50-day SMA
134.2
50-day SMA vs 200-day SMA
50over200
5Y total return
147.26%
All Time High
148.2
All Time High Change
-0.31%
All Time High Date
2026-05-08
All Time Low
32.58
All Time Low Change
353.48%
All Time Low Date
2023-03-28
ATR
3.75
Beta
0.67
Ch YTD
4.98
High
148.2
High52
148.2
High52 Date
2026-05-08
High52ch
-0.31%
Low
146.9
Low52
105.4
Low52 Date
2025-05-23
Low52ch
40.17%
Ma50ch
10.12%
Price vs 200-day SMA
12.97%
RSI
66.11
RSI Monthly
72.99
RSI Weekly
64.26
Sharpe ratio
0.96x
Sortino ratio
1.58
Total Return
1.76%
Tr YTD
4.98
Tr1m
9.39%
Tr1w
8.28%
Tr3m
6.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
SEK 109.4M
Operating Income Growth
14.2
Operating Income Growth Q
21.09
Operating Income Growth3 Y
16.84
Operating Income Growth5 Y
14.26
Operating margin
8.24

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
70,333,790%
Net Borrowing
-6,128,734.4
Shares Insiders
0.93%
Shares Institutions
47.11%
Shares Qo Q
-2.25%
Shares Yo Y
-1.64%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
SEK 157.2M
Average Volume
11,008.7x
Bv Per Share
5.05
CAPEX
SEK -9.7M
Ch1m
9.39
Ch1w
8.28
Ch1y
34.43
Ch3m
6.81
Ch3y
257.7
Ch5y
120
Ch6m
15.67
Change
1.45%
Change From Open
1.19
Close
145.6
Days Gap
0.26
Depreciation Amortization
19,420,924.7
Dollar Volume
1,326,883.5
Earnings Date
2026-05-07
EBIT
SEK 109.4M
EBITDA
SEK 128.8M
EPS
SEK 0.68
F Score
7
FCF
SEK 157.2M
FCF EV Yield
7.83x
Financing CF
-41,299,906
Fiscal Year End
December
Founded
1,993
Goodwill
673,444,443.1
Graham Number
111.83521
Graham Upside
-24.3
Income Tax
SEK 16.6M
Investing CF
-113,475,272
Is Primary Listing
0
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Lynch Fair Value
SEK 138
Lynch Upside
-6.31
Ma150
132.4
Ma150ch
11.62%
Ma20
138.1
Ma20ch
6.96%
Net CF
11,777,237
Next Earnings Date
2026-08-19
Open
146
P FCF Ratio
6.09
P OCF Ratio
5.74
Payment Date
2025-05-21
Position In Range
66.18
Ppne
767,683,684.4
Price Date
2026-05-08
Price EBITDA
SEK 7.43
Relative Volume
0.82x
Revenue
1,327,565,190x
Tax By Revenue
1.25x
Tax Rate
22.64%
Tr6m
15.67%
Volume
8,981
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

LON/0RNX dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.1%
$0.17 annual per share
Payout ratio
+25.9%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+13.7%
3 consecutive years of growth
Total shareholder yield
+1.8%
Next ex-dividend date: 2025-05-15
Performance

LON/0RNX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+37.3%
S&P 500 1Y: n/a
3Y total return
+285.5%
S&P 500 3Y: n/a
5Y total return
+147.3%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/0RNX?

Insider, institutional, and short-interest positioning.

Institutional ownership
+47.1%
Share of float held by funds and institutions
Insider ownership
+0.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-1.6%
Negative means the company is buying back shares.
Technical

LON/0RNX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
66.1
Neutral momentum band
Price vs 200-day MA
+13.0%
50/200-day relationship not available
Beta (5Y)
0.67
Less volatile than the market
Sharpe ratio
0.96
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0RNX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0RNX stock rating?

lon/0RNX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0RNX analysis?

The full report lives at /stocks/lon/0RNX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0RNX?

The latest report frames lon/0RNX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0RNX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.